DNA-Switch Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

DNA-Switch General Information

Description

Developer of gene-based therapies designed to slow or counteract the progression of neurodegenerative diseases. The company offers naturally occurring human genes delivered through viral vectors and messenger ribonucleic acid approaches, enabling healthcare and clinical research organizations to pursue disease-modifying treatments and advance therapeutic development toward patient use.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bologna
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Bologna
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNA-Switch Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Nov-2026 Completed Startup
1. Accelerator/Incubator 16-Apr-2024 Completed Startup
To view DNA-Switch’s complete valuation and funding history, request access »

DNA-Switch Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Panakes Partners Venture Capital Minority
G-Factor Accelerator/Incubator
To view DNA-Switch’s complete investors history, request access »

Ready to get started?

Request a free trial

DNA-Switch FAQs

  • When was DNA-Switch founded?

    DNA-Switch was founded in 2024.

  • Where is DNA-Switch headquartered?

    DNA-Switch is headquartered in Bologna, Italy.

  • What industry is DNA-Switch in?

    DNA-Switch’s primary industry is Drug Discovery.

  • Is DNA-Switch a private or public company?

    DNA-Switch is a Private company.

  • What is DNA-Switch’s current revenue?

    The current revenue for DNA-Switch is .

  • Who are DNA-Switch’s investors?

    Panakes Partners and G-Factor have invested in DNA-Switch.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process